Capture-recapture to estimate the size of the population with human immunodeficiency virus type 1 infection. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Capture-recapture to estimate the size of the population with human immunodeficiency virus type 1 infection.

Epidemiology. 1994 Jul;5(4):410-4. Unique Identifier : AIDSLINE MED/95002340
Abeni DD; Brancato G; Perucci CA; Epidemiology Unit, Lazio Regional Health Authority, Rome, Italy.

Abstract: Estimating and monitoring the total number of people infected with human immunodeficiency virus type 1 (HIV-1) is a critical public health objective. No single epidemiologic methodology yields completely reliable estimates. We used techniques originally designed to estimate the size of wildlife populations to complement estimates of the size of the population with HIV-1 infection in Lazio, Italy, during 1990 obtained from surveillance, surveys, and dynamic mathematical models. We used reports from four large testing sites to generate incomplete, partially overlapping lists of HIV-positive subjects. Log-linear models yielded estimated prevalences of 5.65 per 1,000 among males (95% confidence interval = 4.52-6.78) and 1.84 per 1,000 (95% confidence interval = 1.34-2.33) among females in the population age 15-64 years. This method provides a simple and inexpensive means of obtaining accurate estimates of the total number of HIV seropositives. It could be applied easily in all situations in which data from multiple sources are available.
Keywords: Adult Epidemiologic Methods Female Human HIV Infections/*EPIDEMIOLOGY *HIV Seroprevalence *HIV-1 Italy/EPIDEMIOLOGY Male Models, Theoretical Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadultepidemiologicmethodsfemalehumanhivinfections/KWDepidemiologyKWDhivseroprevalenceKWDhiv-1italy/epidemiologymalemodels,theoreticalsupport,non-uKWDsKWDgov'tjournalarticle
950130
M9510803

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .